Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023

Loading...
Loading...

Upgrades

According to Janney Montgomery Scott, the prior rating for Consolidated Water Co Ltd CWCO was changed from Neutral to Buy. Consolidated Water Co earned $0.26 in the first quarter, compared to $0.15 in the year-ago quarter. The current stock performance of Consolidated Water Co shows a 52-week-high of $20.57 and a 52-week-low of $12.59. Moreover, at the end of the last trading period, the closing price was at $20.15.

According to Jefferies, the prior rating for Veru Inc VERU was changed from Underperform to Hold. For the second quarter, Veru had an EPS of $0.43, compared to year-ago quarter EPS of $0.18. The current stock performance of Veru shows a 52-week-high of $24.52 and a 52-week-low of $0.93. Moreover, at the end of the last trading period, the closing price was at $1.13.

Roth MKM upgraded the previous rating for Yext Inc YEXT from Neutral to Buy. For the first quarter, Yext had an EPS of $0.08, compared to year-ago quarter EPS of $0.06. The stock has a 52-week-high of $9.88 and a 52-week-low of $4.00. At the end of the last trading period, Yext closed at $9.60.

For Petroleo Brasileiro SA Petrobras PBR, Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, Petrobras Brasileiro had an EPS of $1.12, compared to year-ago quarter EPS of $1.32. At the moment, the stock has a 52-week-high of $16.32 and a 52-week-low of $8.88. Petrobras Brasileiro closed at $12.65 at the end of the last trading period.

According to Piper Sandler, the prior rating for Glaukos Corp GKOS was changed from Neutral to Overweight. For the first quarter, Glaukos had an EPS of $0.59, compared to year-ago quarter EPS of $0.38. At the moment, the stock has a 52-week-high of $65.21 and a 52-week-low of $40.50. Glaukos closed at $64.82 at the end of the last trading period.

According to HSBC, the prior rating for Fomento Economico Mexicano SAB de CV FMX was changed from Reduce to Hold. Fomento Economico earned $1.00 in the first quarter, compared to $0.67 in the year-ago quarter. The stock has a 52-week-high of $104.88 and a 52-week-low of $58.74. At the end of the last trading period, Fomento Economico closed at $103.56.

According to HSBC, the prior rating for Coca-Cola Femsa SAB de CV KOF was changed from Hold to Buy. Coca-Cola Femsa SAB de earned $1.00 in the first quarter, compared to $0.67 in the year-ago quarter. The stock has a 52-week-high of $91.23 and a 52-week-low of $52.01. At the end of the last trading period, Coca-Cola Femsa SAB de closed at $85.11.

According to Wedbush, the prior rating for NovoCure Ltd NVCR was changed from Underperform to Neutral. NovoCure earned $0.50 in the first quarter, compared to $0.04 in the year-ago quarter. The stock has a 52-week-high of $120.03 and a 52-week-low of $46.06. At the end of the last trading period, NovoCure closed at $47.00.

See all analyst ratings upgrades.

Downgrades

For EPAM Systems Inc EPAM, Citigroup downgraded the previous rating of Buy to Neutral. For the first quarter, EPAM Sys had an EPS of $2.47, compared to year-ago quarter EPS of $2.49. The stock has a 52-week-high of $462.52 and a 52-week-low of $197.99. At the end of the last trading period, EPAM Sys closed at $208.77.

According to Truist Securities, the prior rating for Amedisys Inc AMED was changed from Buy to Hold. For the first quarter, Amedisys had an EPS of $1.00, compared to year-ago quarter EPS of $1.23. The current stock performance of Amedisys shows a 52-week-high of $131.28 and a 52-week-low of $69.36. Moreover, at the end of the last trading period, the closing price was at $92.37.

According to HC Wainwright & Co., the prior rating for Check-Cap Ltd CHEK was changed from Buy to Neutral. In the first quarter, Check-Cap showed an EPS of $0.76, compared to $1.13 from the year-ago quarter. The current stock performance of Check-Cap shows a 52-week-high of $9.20 and a 52-week-low of $1.22. Moreover, at the end of the last trading period, the closing price was at $1.95.

For Paratek Pharmaceuticals Inc PRTK, HC Wainwright & Co. downgraded the previous rating of Buy to Neutral. In the first quarter, Paratek Pharmaceuticals showed an EPS of $0.35, compared to $0.35 from the year-ago quarter. The current stock performance of Paratek Pharmaceuticals shows a 52-week-high of $3.65 and a 52-week-low of $1.29. Moreover, at the end of the last trading period, the closing price was at $2.17.

For Staar Surgical Co STAA, William Blair downgraded the previous rating of Outperform to Market Perform. In the first quarter, Staar Surgical showed an EPS of $0.18, compared to $0.29 from the year-ago quarter. At the moment, the stock has a 52-week-high of $112.23 and a 52-week-low of $46.41. Staar Surgical closed at $54.79 at the end of the last trading period.

According to Oppenheimer, the prior rating for Chemomab Therapeutics Ltd CMMB was changed from Outperform to Perform. For the first quarter, Chemomab Therapeutics had an EPS of $0.80, compared to year-ago quarter EPS of $0.02. The stock has a 52-week-high of $5.35 and a 52-week-low of $1.38. At the end of the last trading period, Chemomab Therapeutics closed at $1.72.

According to Jefferies, the prior rating for Paratek Pharmaceuticals Inc PRTK was changed from Buy to Hold. In the first quarter, Paratek Pharmaceuticals showed an EPS of $0.35, compared to $0.35 from the year-ago quarter. The current stock performance of Paratek Pharmaceuticals shows a 52-week-high of $3.65 and a 52-week-low of $1.29. Moreover, at the end of the last trading period, the closing price was at $2.17.

According to JMP Securities, the prior rating for Duolingo Inc DUOL was changed from Market Outperform to Market Perform. For the first quarter, Duolingo had an EPS of $0.06, compared to year-ago quarter EPS of $0.31. The current stock performance of Duolingo shows a 52-week-high of $168.40 and a 52-week-low of $64.73. Moreover, at the end of the last trading period, the closing price was at $167.05.

See all analyst ratings downgrades.

Initiations

For Integral Ad Science Holding Corp IAS, Benchmark initiated coverage, by setting the current rating at Hold. For the first quarter, Integral Ad Science had an EPS of $0.02, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of $19.44 and a 52-week-low of $6.64. At the end of the last trading period, Integral Ad Science closed at $19.19.

With a Sell rating, Odeon Capital initiated coverage on Bank of Hawaii Corp BOH. The price target seems to have been set at $31.00 for Bank of Hawaii. In the first quarter, Bank of Hawaii showed an EPS of $1.14, compared to $1.32 from the year-ago quarter. At the moment, the stock has a 52-week-high of $85.38 and a 52-week-low of $30.83. Bank of Hawaii closed at $44.88 at the end of the last trading period.

Canaccord Genuity initiated coverage on Mobileye Global Inc MBLY with a Buy rating. The price target for Mobileye Global is set to $50.00. Mobileye Global earned $0.14 in the first quarter, compared to $0.16 in the year-ago quarter. The current stock performance of Mobileye Global shows a 52-week-high of $48.11 and a 52-week-low of $24.86. Moreover, at the end of the last trading period, the closing price was at $42.32.

With a Buy rating, Canaccord Genuity initiated coverage on Aurora Innovation Inc AUR. The price target seems to have been set at $5.00 for Aurora Innovation. Aurora Innovation earned $0.17 in the first quarter, compared to $0.13 in the year-ago quarter. At the moment, the stock has a 52-week-high of $3.29 and a 52-week-low of $1.10. Aurora Innovation closed at $1.52 at the end of the last trading period.

Raymond James initiated coverage on Reinsurance Group of America Inc RGA with a Strong Buy rating. The price target for Reinsurance Gr is set to $199.00. In the first quarter, Reinsurance Gr showed an EPS of $5.16, compared to $0.47 from the year-ago quarter. The current stock performance of Reinsurance Gr shows a 52-week-high of $153.35 and a 52-week-low of $109.11. Moreover, at the end of the last trading period, the closing price was at $142.70.

With a Buy rating, HC Wainwright & Co. initiated coverage on Disc Medicine Inc IRON. The price target seems to have been set at $55.00 for Disc Medicine. Disc Medicine earned $1.20 in the first quarter, compared to $10.67 in the year-ago quarter. The current stock performance of Disc Medicine shows a 52-week-high of $211.50 and a 52-week-low of $13.50. Moreover, at the end of the last trading period, the closing price was at $39.17.

With a Buy rating, Jefferies initiated coverage on Terns Pharmaceuticals Inc TERN. The price target seems to have been set at $18.00 for Terns Pharma. Terns Pharma earned $0.31 in the first quarter, compared to $0.55 in the year-ago quarter. The current stock performance of Terns Pharma shows a 52-week-high of $14.04 and a 52-week-low of $1.70. Moreover, at the end of the last trading period, the closing price was at $11.63.

With a Neutral rating, Mizuho initiated coverage on Herbalife Ltd HLF. The price target seems to have been set at $13.00 for Herbalife. For the first quarter, Herbalife had an EPS of $0.54, compared to year-ago quarter EPS of $0.99. At the moment, the stock has a 52-week-high of $30.65 and a 52-week-low of $11.14. Herbalife closed at $12.25 at the end of the last trading period.

Rosenblatt initiated coverage on Super Micro Computer Inc SMCI with a Buy rating. The price target for Super Micro Computer is set to $300.00. For the third quarter, Super Micro Computer had an EPS of $1.63, compared to year-ago quarter EPS of $1.55. The stock has a 52-week-high of $242.99 and a 52-week-low of $37.04. At the end of the last trading period, Super Micro Computer closed at $233.15.

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...